Clinical trial · Observational
Blood Glycan Biomarkers in Women With Stage IV Breast Cancer
Serum Glycan Analysis in Breast Cancer
NCT00897962CI-TRIAL-00036273completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood glycan biomarkers in women with stage IV breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Healthy Controls | Other | — | UNRESOLVED |
| Metastatic Breast Cancer | Other | — | UNRESOLVED |
| Non-cancer medical illness | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Metastatic Breast Cancer
- description
- Patients with metastatic breast cancer receiving treatment with chemotherapy, endocrine therapy or targeted therapy
- interventionNames
- Other: Metastatic Breast Cancer
- label
- Non-cancer medical illness
- description
- Patients with non-cancer medical condition
- interventionNames
- Other: Non-cancer medical illness
- label
- Healthy Controls
- description
- Healthy patients being seen for an annual exam
- interventionNames
- Other: Healthy Controls
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS:
* Patient or participant at the Women's Health Clinic, the Internal Medicine Clinic, or at the UC Davis Cancer Center, meeting 1 of the following criteria:
* Diagnosis of stage IV metastatic breast cancer, receiving active treatment with chemotherapy, endocrine therapy, or targeted therapy
* Patients/participants without cancer
* Healthy control being seen for annual exams, meeting the following criteria:
* No chronic disease
* Not on regular prescribed medications
* Patient without cancer being seen in the Internal Medicine Clinic
* Hormone receptor status not specified
PATIENT CHARACTERISTICS:
* Menopausal status not specified
* Not pregnant or breast feeding
* No other active cancer
PRIOR CONCURRENT THERAPY:
* See Disease CharacteristicsReferences
Publications (0)
Data not yet available
No reference posted for this study.